ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MNKD Stock Price » MNKD Stock News

Mannkind Share News

 Mannkind (mm) Stock Price
MNKD Stock Price
 Mannkind (mm) Stock Chart
MNKD Stock Chart
 Mannkind (mm) Stock News
MNKD Stock News
 Mannkind (mm) Company Information
MNKD Company Information
 Mannkind (mm) Stock Trades
MNKD Stock Trades

MannKind To Offer 8 Million Shares, Agrees To Share Lending Pact

DOW JONES NEWSWIRES MannKind Corp. (MNKD) announced Monday that it would offer up to 8 million shares, as the biopharmaceutical company said it would enter into a share-lending agreement with Bank of America Corp. (BAC). Shares of the company, which develops and markets therapeutic products to treat diabetes, cancer and other diseases, fell 6.9% to $6.35 in after-hours trading. As of Monday's close, the stock is down 22% in the year to date. Bank of America's Merrill Lynch intends to sell the borrowed shares in the common stock offering and to use the resulting short position to facilitate short sales and privately negotiated derivative transactions by which some investors in a concurrent offering of $100 million of notes due in 2015 may hedge their investment in the notes. MannKind won't receive any proceeds from the offering, but will receive a one-time loan fee. Bank of America will be required to return the borrowed shares pursuant to the terms of the lending agreement. The news came after MannKind last week said it planned to issue as many as 36.4 million shares in separate deals to Mann Group LLC and private investment firm Seaside 88 LP as it works to reduce its debt. The company recently had about 114 million shares outstanding. -By John Kell, Dow Jones Newswires; 212-416-2480;

Stock News for Mannkind (MNKD)
05/23/201510:04:02Could Incoming Threats Sink MannKind Corporation?
05/21/201510:30:00James S. Shannon Rejoins MannKind's Board of Directors
05/21/201508:59:02MannKind, Front and Center: The Best Product Doesnât Always E...
05/19/201511:36:02Forget MannKind Stock's Price: Here's What You Need to Focus...
05/17/201510:04:024 Reasons Why MannKind Could Succeed Where Pfizer Failed
05/15/201516:02:03Why MannKind Stock Got New Life Breathed Into It Today
05/15/201515:48:11Why MannKind Stock Got New Life Breathed Into It Today
05/11/201517:30:37Quarterly Report (10-q)
05/08/201515:07:59Amended Statement of Ownership (sc 13g/a)
05/08/201512:01:33Why Shares in MannKind Corp. Are Tumbling
05/08/201506:05:16Current Report Filing (8-k)
05/07/201518:48:29MannKind Corporation Reports 2015 First Quarter Financial Results
05/07/201511:59:02The Best Company for Investing in the Diabetes Market
05/07/201508:17:02Here's Why MannKind Corporation Was Clobbered in April
05/06/201517:00:00MannKind to Present at Bank of America Merrill Lynch 2015 Healthcare...
05/03/201509:19:02In Case You Missed It, This New Study Suggests America Is a Nation...
04/30/201517:00:00MannKind Corporation to Hold 2015 First Quarter Financial Results...
04/29/201509:09:02MannKind's Future: More than Just Afrezza?
04/28/201517:42:57Statement of Changes in Beneficial Ownership (4)
04/27/201512:31:32Current Report Filing (8-k)

Mannkind and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations